Vertex Pharmaceuticals, Inc. (VRTX)

463.31 +4.10 (+0.89%) USD  |  NASDAQ  |  Dec 24, 10:39
More

Vertex Pharmaceuticals SG&A Expense (TTM): 1.644B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Amgen, Inc. 6.976B
Eli Lilly & Co. 10.39B
IDEXX Laboratories, Inc. 1.024B
Regeneron Pharmaceuticals, Inc. 2.717B